logo
  • 首页
  • 学术期刊
  • 论文检测
  • AIGC检测
  • 热点
  • 更多
    • 数据

Ipilimumab/nivolumabImmune-mediated colitis complicated by hypokalaemia and QT interval prolongation: case report

被引:0
|
作者:
机构:
来源:
Reactions Weekly | 2020年 / 1790卷 / 1期
关键词:
D O I:
10.1007/s40278-020-74759-7
中图分类号:
学科分类号:
摘要:
引用
收藏
页码:140 / 140
相关论文
共 50 条
  • [1] Ipilimumab/nivolumabImmune-mediated colitis: case report
    Reactions Weekly, 2021, 1836 (1) : 437 - 437
  • [2] Ipilimumab/nivolumabImmune-mediated colitis: case report
    Reactions Weekly, 2021, 1836 (1) : 436 - 436
  • [3] Ipilimumab/nivolumabImmune-mediated colitis: case report
    Reactions Weekly, 2018, 1729 (1) : 151 - 151
  • [4] Ipilimumab/nivolumabImmune-mediated colitis: case report
    Reactions Weekly, 2024, 2022 (1) : 155 - 155
  • [5] Ipilimumab/nivolumabImmune-mediated colitis : case report
    Reactions Weekly, 2021, 1885 (1) : 281 - 281
  • [6] Ipilimumab/nivolumabImmune-mediated colitis and immune-mediated dermatitis: case report
    Reactions Weekly, 2021, 1836 (1) : 435 - 435
  • [7] NivolumabImmune-mediated colitis: case report
    Reactions Weekly, 2025, 2041 (1) : 308 - 308
  • [8] Ipilimumab/methylprednisolone/nivolumabImmune-mediated colitis and lack of efficacy: case report
    Reactions Weekly, 2022, 1927 (1) : 304 - 304
  • [9] NivolumabImmune-mediated colitis: case report
    Reactions Weekly, 2023, 1959 (1) : 509 - 509
  • [10] Ipilimumab/nivolumabImmune-mediated thyroiditis: case report
    Reactions Weekly, 2023, 1957 (1) : 311 - 311
← 12345 →